Firstwave Cloud Technology Ltd Files AI Network Fault Diagnosis Patent [VIDEO]
FirstWave Cloud Technology (ASX: FCT) has filed a provisional patent for an AI-driven network fault diagnosis system targeting the on-premise segment that cloud AI cannot reach — built on the network monitoring line that already grew 34% to A$6.9 million in FY26.
Key Takeaways
- FirstWave filed provisional patent application 2026907532 with IP Australia on 3 September 2026 for a multi-agent AI network fault diagnosis system built directly into its NMIS platform.
- Network monitoring — the revenue line the patent is designed to extend — grew 34% to A$6,932,196 in FY26, making this a bet on the company's strongest and fastest-growing segment.
- John Deere and Telmex have already requested this capability, providing named blue-chip demand validation ahead of a commercial launch that FirstWave describes as imminent but has not dated.
- The on-premise deployment model targets the approximately 53% of the network management market that cloud-delivered AI cannot access, including banks, defence, government, and telcos — a segment already proven by Services Australia's $1.85 million licence deal in 2026.
- The invention was co-developed with CSIRO and the University of the Sunshine Coast under the RUIC program, with FirstWave holding the patent outright as sole applicant and owner.
![Immuron Ltd Secures Exclusive US Distribution Rights for PROIBS in $4.16B Market [VIDEO]](https://media.stockwirex.com/IMC-Store-Display.jpg)
![Hubify Ltd Frames 89% EBITDA Lift Around AI First Managed Intelligence Pivot [VIDEO]](https://media.stockwirex.com/data_center_hfy.jpg)
![Aland Equity Group Locks in Rights to Sell 56 Lots Targeting $75K Net Per Lot [VIDEO]](https://media.stockwirex.com/land-for-sale-sign.jpg)
Breaking ASX Alerts Direct to Your Inbox
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
- Breaking ASX announcements delivered within minutes
- Alerts delivered with expert analysis
- Optional text alert for subscribers
- No spam policy, unsubscribe any time
About the Publisher
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
Disclaimer
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X Pty Ltd (CAR No. 001 322 642) is a Corporate Authorised Representative of ShareX Pty Ltd (AFSL No. 519872), regulated by the Australian Securities and Investments Commission (ASIC). StockWire X is authorised to provide general financial product advice in relation to basic deposit products, securities, and managed investment schemes.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
Disclosure
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
Disclaimer